Proposal for the design of studies of intramammary antimicrobials to be conducted in Brazil for registration with the Ministry of Agriculture and Livestock
DOI:
https://doi.org/10.11606/issn.1678-4456.bjvras.2024.219031Keywords:
Intramammary antimicrobial product, Bovine mastitis, Clinical study design, Veterinary drug, MAPA regulatoryAbstract
Before being made available to the Brazilian market, all veterinary medicines must be registered with the Ministry of Agriculture and Livestock after their efficacy, safety, and quality have been proven through clinical studies and scientific literature. Depending on the product class, the studies required by the regulatory authority must be carried out per Brazilian regulations and international reference guides. Some international organizations pursue the harmonization of these requirements, aiming at the mutual acceptance of studies conducted in different regions to facilitate international trade and reduce the use of animals in clinical research. Mastitis is one of the most prevalent and costly diseases in dairy cows, and it is associated with negative impacts on milk production and quality, cow welfare, and the profitability of the dairy industry. Normative Instruction No. 26/2009 determines a few rules for conducting studies for registering intramammary antimicrobials for cows with mastitis. However, the regulated sector and researchers report difficulties in following the recommendations of specific guidelines, which complement this regulation due to the peculiarities of Brazil’s production systems. This review article aims to provide subsidies and orientations that scientifically support the conduction and critical analysis of clinical studies proving the efficacy of intramammary products for treating clinical and subclinical mastitis in cows. Considering the need for scientific rigor in the studies, the recommendations available in international guidelines, and the need to adapt the protocols to the current situation of veterinary clinical research in Brazil, this document is intended to contribute to the internal harmonization of experimental protocols that support both the regulated sector and the regulatory authority.
Downloads
References
Abdi RD, Gillespie BE, Ivey S, Pighetti GM, Almeida RA, Kerro Dego O. Antimicrobial resistance of major bacterial pathogens from dairy cows with high somatic cell count and clinical mastitis. Animals. 2021;11(1):131. http://doi.org/10.3390/ani11010131. PMid:33430135.
Adkins PRF, Middleton JR. Methods for diagnosing mastitis. Vet Clin North Am Food Anim Pract. 2018;34(3):479-91. PMid:30316505.
Aghamohammadi M, Haine D, Kelton DF, Barkema HW, Hogeveen H, Keefe GP, Dufour S. Herd-level mastitis associated costs on Canadian dairy farms. Front Vet Sci. 2018;5:100. http://doi.org/10.3389/fvets.2018.00100. PMid:29868620.
Ashraf A, Imran M. Diagnosis of bovine mastitis: from laboratory to farm. Trop Anim Health Prod. 2018;50(6):1193-202. http://doi.org/10.1007/s11250-018-1629-0. PMid:29948774.
Australian Pesticides and Veterinary Medicines Authority. Guidelines for registration of intramammary preparations for treatment of bovine mastites [Internet]. Sidney; 2023 [cited 2023 Nov 18]. Available from: https://apvma.gov.au/node/445.
Brasil. Ministério da Agricultura, Pecuária e Abastecimento. Decreto-lei nº 467, de 13 de fevereiro de 1969 [Internet]. Diário Oficial da União; Brasília; 1969 Feb 14 [cited 2023 Nov 18]. Available from: https://www.gov.br/agricultura/pt-br/assuntos/insumos-agropecuarios/insumos-pecuarios/produtos-veterinarios/legislacao-1/decreto-lei-e-lei/decreto-lei-no-467-de-13-02-1969.pdf.
Brasil. Ministério da Agricultura, Pecuária e Abastecimento. Decreto nº 5.053, de 22 de abril de 2004 [Internet]. Diário Oficial da União; Brasília; 2004 Apr 23 [cited 2023 Nov 18]. Available from: https://www.planalto.gov.br/ccivil_03/_ato2004-2006/2004/decreto/d5053.htm.
Brasil. Ministério da Agricultura, Pecuária e Abastecimento. Instrução normativa nº 26, de 9 de julho de 2009 [Internet]. Diário Oficial da União; Brasília; 2009 Jul 10 [cited 2023 Nov 18]. Available from: https://www.gov.br/agricultura/pt-br/assuntos/insumos-agropecuarios/insumos-pecuarios/alimentacao-animal/arquivos-alimentacao-animal/legislacao/instrucao-normativa-no-26-de-9-de-julho-de-2009.pdf.
Brasil. Ministério da Agricultura, Pecuária e Abastecimento. Painéis de Business Intelligence (BI) do MAPA: produtos veterinários farmacêuticos registrados [Internet]. Brasília; 2023 [cited 2023 Nov 10]. Available from: https://mapa-indicadores.agricultura.gov.br/publico/single/?appid=a3e9ce67-d63b-43ff-a295-20123996ead7&sheet=4c2ec12f-be27-47f2-8136-e2fd18cbb54a&lang=pt-BR&opt=ctxmenu&select=clearall.
Brasil. Ministério da Ciência, Tecnologia e Inovações. Conselho Nacional de Controle de Experimentação Animal. Resolução Normativa nº 25, de 29 de setembro de 2015. Guia brasileiro de produção, manutenção ou utilização de animais para atividades de ensino ou pesquisa científica do CONCEA [Internet]. Diário Oficial da União; Brasília; 2015 [cited 2023 Nov 18]. Available from: https://antigo.mctic.gov.br/mctic/opencms/legislacao/outros_atos/resolucoes/migracao/Resolucao_Normativa_CONCEA_n_25_de_29092015.html.
DeGraves FJ, Fetrow J. Economics of mastitis and mastitis control. Vet Clin North Am Food Anim Pract. 1993;9(3):421-34. http://doi.org/10.1016/S0749-0720(15)30611-3. PMid:8242449.
European Medicines Agency. EMA/CVMP/344/1999-Rev.2: guideline on the conduct of efficacy studies for intramammary products for use in cattle [Internet]. London: EMA; 2017b [cited 2023 Nov 18]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-conduct-efficacy-studies-intramammary-products-use-cattle_en.pdf.
European Medicines Agency. EMA/CVMP/627/2001 REV. 1: guideline for the demonstration of efficacy for veterinary medicinal products containing ATM substances [Internet]. London: EMA; 2016 [cited 2023 Nov 18]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-demonstration-efficacy-veterinary-medicinal-products-containing-antimicrobial-substances_en-0.pdf.
European Medicines Agency. EMA/CVMP/EWP/81976/2010: Guideline on statistical principles for clinical trials for veterinary medicinal products (pharmaceuticals) [Internet]. Amsterdam: EMA; 2022 [cited 2023 Nov 18]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-statistical-principles-clinical-trials-veterinary-medicinal-products-pharmaceuticals-rev-1_en.pdf.
Fernández-Varón E, García-Romero E, Serrano-Rodríguez JM, Cárceles CM, García-Galán A, Cárceles-García C, Fernández R, Muñoz C, de la Fe C. PK/PD analysis of marbofloxacin by monte carlo simulation against Mycoplasma agalactiae in plasma and milk of lactating goats after IV, SC and SC-Long acting formulations administration. Animals (Basel). 2021;11(4):1104. http://doi.org/10.3390/ani11041104. PMid:33921496.
Fredebeul-Krein F, Schmenger A, Wente N, Zhang Y, Krömker V. Factors associated with the severity of clinical mastitis. Pathogens. 2022;11(10):1089. http://doi.org/10.3390/pathogens11101089. PMid:36297146.
Gehring R, Smith GW. An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis. J Vet Pharmacol Ther. 2006;29(4):237-41. http://doi.org/10.1111/j.1365-2885.2006.00750.x. PMid:16846460.
International Dairy Federation. Guidelines for the use and interpretation of bovine somatic cell counts (SCC) in the dairy industry [Internet]. Brussels: IDF; 2013. (Bulletin of the IDF; no. 466) [cited 2023 Nov 18]. Available from: https://shop.fil-idf.org/products/guidelines-for-the-use-and-interpretation-of-bovine-milk-somatic-cell-counts-scc-in-the-dairy-industry.
Li M, Gehring R, Riviere JE, Lin Z. Probabilistic Physiologically Based Pharmacokinetic Model for Penicillin G in Milk From Dairy Cows Following Intramammary or Intramuscular Administrations. Toxicol Sci. 2018;164(1):85-100. http://doi.org/10.1093/toxsci/kfy067. PMid:29945226.
Martin CC. Uso de antimicrobianos nos sistemas de produção de leite nas categorias vacas e bezerras lactentes [tese]. São Paulo: Universidade de São Paulo, Faculdade de Medicina Veterinária e Zootecnia; 2022. http://doi.org/10.11606/T.10.2022.tde-04052023-121121.
National Mastitis Council. Guidelines on normal and abnormal raw milk based on somatic cell counts and signs of clinical mastitis [Internet]. New Prague; 2001 [cited 2023 Nov 18]. Available from: https://www.nmconline.org/wp-content/uploads/2016/09/Guidelines-on-Normal-and-Abnormal-Raw-Milk.pdf.
Ruegg PL. 100-year review: mastitis detection, management, and prevention. J Dairy Sci. 2017;100(12):10381-97. http://doi.org/10.3168/jds.2017-13023. PMid:29153171.
Ruegg PL. What is success? A narrative review of research evaluating outcomes of antibiotics used for treatment of clinical mastitis. Front Vet Sci. 2021;8:639641. http://doi.org/10.3389/fvets.2021.639641. PMid:33604368.
Seegers H, Fourichon C, Beaudeau F. Production effects related to mastitis and mastitis economics in dairy cattle herds. Vet Res. 2003;34(5):475-91. http://doi.org/10.1051/vetres:2003027. PMid:14556691.
Smith KL, Hillerton JE, Harmon RJ. Guidelines on normal and abnormal raw milk based on somatic cell counts and signs of clinical mastitis. Prague: National Mastitis Council; 2001 [cited 2002 Jul 9]. Available from: http://www.nmconline.org/docs/abnmilk.htm.
South Africa. Medicines Control Council. Department of Health. Veterinary antimastitis medicines [Internet]. Republic of South Africa; 2013 [cited 2023 Nov 18]. Available from: https://www.sahpra.org.za/wp-content/uploads/2020/01/1b9f09f13.13_Veterinary_Antimastitis_Medicines_Jun13_v1.pdf.
Tang KL, Caffrey NP, Nóbrega DB, Cork SC, Ronksley PE, Barkema HW, Polachek AJ, Ganshorn H, Sharma N, Kellner JD, Ghali WA. Restricting the use of antibiotics in food-producing animals and its associations with antibiotic resistance in food-producing animals and human beings: a systematic review and meta-analysis. Lancet Planet Health. 2017;1(8):e316-27. http://doi.org/10.1016/S2542-5196(17)30141-9. PMid:29387833.
Thorburn MA. General principles for the design of clinical trials with special reference to mastitis therapy. Bulletin of the International Dairy Federation. 1990;247:39-48 [cited 2023 Nov 18]. Available from: https://www.fil-idf.org/wp-content/uploads/2021/02/B321_1997_Recommendations-for-Presentation-of-Mastitis-Related-Date_Guidelines-Evaluation-of-the-Milking-Process-Secured.pdf.
U.S. Food & Drug Administration. Center for Veterinary Medicine. CVM GFI #49 target animal safety and drug effectiveness studies for anti-microbial bovine mastitis products (lactating and non-lactating cow products) [Internet]. Rockville: FDA; 2018 [cited 2023 Nov 18]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cvm-gfi-49-target-animal-safety-and-drug-effectiveness-studies-anti-microbial-bovine-mastitis.
United States Department of Agriculture. Foreign Agricultural Service. Dairy: world markets and trade [Internet]. Washington, D.C.: FAS; 2023 [cited 2023 Nov 18]. Available from: https://apps.fas.usda.gov/psdonline/circulars/dairy.pdf.
VidaVet [Internet]. 2023 [cited 2023 Nov 18]. Available from: www.vidavet.com.br.
Zambelli LSF. Dinâmica da prevalência de patógenos causadores de mastite em propriedades leiteiras brasileiras de 2012 a 2020 e associação com ano e estação de ano [dissertação]. Botucatu: Faculdade de Medicina Veterinária e Zootecnia, Universidade Estadual Paulista “Júlio de Mesquita Filho”; 2023. 94 p.
Ziv G, Sulman FG. Absorption antibiotics by the bovine udder. J Dairy Sci. 1975;58(11):1637-44. http://doi.org/10.3168/jds.S0022-0302(75)84762-X. PMid:1194466.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Brazilian Journal of Veterinary Research and Animal Science
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal content is authorized under the Creative Commons BY-NC-SA license (summary of the license: https://
